Bharat Biotech`s Covaxin gets approval for phase 2/3 trials on 2-18 year-olds https://ift.tt/eA8V8J - Sarkari NEWS

Breaking

Sarkari NEWS

This is one of the best website to get news related to new rules and regulations setup by the government or any new scheme introduced by the government. This website will provide the news on various governmental topics so as to make sure that the words and deeds of government reaches its people. And the people must've aware of what the government is planning, what all actions are being taken. All these things will be covered in this website.

Tuesday, May 11, 2021

Bharat Biotech`s Covaxin gets approval for phase 2/3 trials on 2-18 year-olds https://ift.tt/eA8V8J

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.

from Zee News :India National https://ift.tt/3o8FPAA
via IFTTT
Read more
Author Image

About TheBlogger
SoraTemplates is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of SoraTemplates is to provide the best quality blogger templates.

By -
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)